Aytu BioPharma, Inc.

Form DEF 14A AYTU BIOPHARMA For: 22 October By Investing.com
Investing.com India · 22 Oct 2026
Aytu BioPharma at lytham partners fall 2026: exxua drives shift By Investing.com
Investing.com India · 30 Sep 2026
Aytu BioPharma Reports $16.1 Million In Fourth-Quarter Revenue As EXXUA Sales Reach $3.9 Million
Pulse 2.0 · 24 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.